AngioDynamics (STU:UG2) Cyclically Adjusted FCF per Share: €0.22 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UG2 AngioDynamics Inc STU:UG2
66 GF Score
Price €11.80
GF Value €8.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is AngioDynamics Cyclically Adjusted FCF per Share?

AngioDynamics STU:UG2 -3.28% 66 Cyclically Adjusted FCF per Share is €0.22 as of May. 2026. GuruFocus rates STU:UG2 with a GF Score™ of 66/100 and a GF Value™ of €8.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

AngioDynamics's adjusted free cash flow per share for the three months ended in May. 2026 was €0.350. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.22 for the trailing ten years ended in May. 2026.

During the past 12 months, AngioDynamics's average Cyclically Adjusted FCF Growth Rate was -33.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -23.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -16.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of AngioDynamics was 18.20% per year. The lowest was -23.50% per year. And the median was -6.50% per year.

As of today (2026-07-18), AngioDynamics's current stock price is €11.80. AngioDynamics's Cyclically Adjusted FCF per Share for the quarter that ended in May. 2026 was €0.22. AngioDynamics's Cyclically Adjusted Price-to-FCF of today is 53.64.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AngioDynamics was 52.75. The lowest was 10.83. And the median was 23.29.


AngioDynamics  (STU:UG2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

AngioDynamics's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=11.80/0.22
=53.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AngioDynamics was 52.75. The lowest was 10.83. And the median was 23.29.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


AngioDynamics Cyclically Adjusted FCF per Share Related Terms


AngioDynamics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for AngioDynamics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Cyclically Adjusted FCF per Share Chart

AngioDynamics Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.53 0.43 0.33 0.22

AngioDynamics Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.28 0.27 0.23 0.22

STU:UG2 vs NNNN, OSUR, UTMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Cyclically Adjusted Price-to-FCF falls into.


STU:UG2
66GF Score
AngioDynamics Inc STU:UG2
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AngioDynamics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AngioDynamics's adjusted Free Cash Flow per Share data for the three months ended in May. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of May. 2026 (Change)*Current CPI (May. 2026)
=0.35/335.1230*335.1230
=0.350

Current CPI (May. 2026) = 335.1230.

AngioDynamics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201608 0.169 240.849 0.235
201611 0.339 241.353 0.471
201702 0.353 243.603 0.486
201705 0.449 244.733 0.615
201708 0.058 245.519 0.079
201711 0.215 246.669 0.292
201802 0.057 248.991 0.077
201805 0.524 251.588 0.698
201808 -0.222 252.146 -0.295
201811 0.287 252.038 0.382
201902 0.175 252.776 0.232
201905 0.575 256.092 0.752
201908 -0.192 256.558 -0.251
201911 0.074 257.208 0.096
202002 -0.472 258.678 -0.611
202005 0.058 256.394 0.076
202008 -0.161 259.918 -0.208
202011 0.223 260.229 0.287
202102 0.097 263.014 0.124
202105 0.247 269.195 0.307
202108 -0.218 273.567 -0.267
202111 0.018 277.948 0.022
202202 -0.223 283.716 -0.263
202205 0.182 292.296 0.209
202208 -0.655 296.171 -0.741
202211 0.168 297.711 0.189
202302 0.004 300.840 0.004
202305 0.346 304.127 0.381
202308 -0.612 307.026 -0.668
202311 0.108 307.051 0.118
202402 -0.377 310.326 -0.407
202405 0.101 314.069 0.108
202408 -0.432 314.796 -0.460
202411 0.039 315.493 0.041
202502 -0.351 319.082 -0.369
202505 0.390 321.465 0.407
202508 -0.347 323.976 -0.359
202511 0.088 324.122 0.091
202602 -0.084 326.785 -0.086
202605 0.350 335.123 0.350

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.22 mean?
AngioDynamics (STU:UG2) has a Cyclically Adjusted FCF per Share of €0.22 as of May. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AngioDynamics and its competitors.
Is AngioDynamics' Cyclically Adjusted FCF per Share too high?
AngioDynamics' current Cyclically Adjusted FCF per Share is €0.22. Overall, AngioDynamics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' Cyclically Adjusted FCF per Share compare to NNNN and OSUR?
AngioDynamics' Cyclically Adjusted FCF per Share of €0.22 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AngioDynamics and its competitors. AngioDynamics's current Cyclically Adjusted FCF per Share is €0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
Based on GuruFocus' analysis, AngioDynamics (STU:UG2) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.32, compared to a current price of €11.80 — trading 41.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.22. AngioDynamics' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For AngioDynamics (STU:UG2), the current Cyclically Adjusted FCF per Share is €0.22 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (STU:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €11.80 is trading 41.8% above its estimated GF Value™ of €8.32. GuruFocus considers AngioDynamics to be Significantly Overvalued.

Key valuation signals for STU:UG2:

  • Cyclically Adjusted FCF per Share: €0.22
  • GF Value™: €8.32 vs. price of €11.80 (41.8% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the STU:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
66GF Score

Get the complete analysis for STU:UG2

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€8.32
GF Value